Analysis from Israel

One of the BDS movement’s greatest assets is the fact that its every success gets massive media coverage while its failures (ScarJo excepted) are largely ignored. That’s why anyone following the news in recent weeks would probably conclude that boycott, divestment, and sanctions were rapidly gaining ground. Yet in reality, BDS has suffered several major failures lately–and some of these failures bode ill for its future.

Just last week, for instance, Britain’s Supreme Court issued a major ruling against BDS when it upheld a trespassing conviction against four activists who chained themselves in an Ahava shop in London to protest the Israeli cosmetics firm’s West Bank plant. Far from being a narrow decision about trespassing, the ruling tackled the activists’ allegations against Ahava head-on.

First, the court rejected the claim that Ahava was “aiding and abetting the transfer of Israeli citizens to the OPT [Occupied Palestinian Territories],” and thereby violating the Geneva Convention. The company was doing no such thing, it said, but even if it were, “this could not amount to an offense by Ahava’s retailing arm.” That precedent will clearly be valuable for other Israeli companies fighting BDS.

Second, the court rejected the claim that Ahava had mislabeled its goods by labeling them “made in Israel” when they were made in the West Bank–another precedent of obvious value. Moreover, its reasoning demonstrated a remarkably clear understanding of what BDS is about: The label isn’t misleading, it said, because “a consumer willing to buy Israeli products would be very unlikely not to buy Israeli products because they were produced in the OPT.” In short, the court understood that most boycotters aren’t just “anti-occupation”; they have a problem with Israel, period. That understanding is crucial to unmasking BDS for what it is.

Also last week, Holland’s largest pension fund–and the world’s third largest–took the unusual step of issuing a press statement announcing that it had no intention of divesting from Israeli banks, having “concluded that these banks themselves do not act in breach of international laws and regulations, and that there are no judicial rulings that should lead to their exclusion.” ABP’s statement was a direct challenge to Holland’s second largest pension fund, PGGM, which last month announced plans to divest from Israeli banks because of their involvement in financing the settlements. PGGM had claimed such activity was problematic from the standpoint of international law. Now its larger crosstown rival has just publicly termed that nonsense. Such a rebuttal from a major European financial institution is far more convincing than anything Israel could say.

Two weeks earlier, BDS suffered another loss in a French court. The French distributor for the Israeli firm SodaStream, which also has a West Bank plant, had sued a local pro-boycott group for claiming that SodaStream products were being sold fraudulently because they were labeled “made in Israel.” The court found the claim that the distributor was deceiving or defrauding customers to be baseless. It therefore fined the group and ordered it to halt its campaign. As with the British ruling, this precedent will be very useful to other Israeli companies.

Moreover, many recent BDS “victories” are actually optical illusions. Take, for instance, the announcement by Denmark’s largest bank that it’s divesting from Bank Hapoalim. But as Hapoalim pointed out, “Denmark’s Danske Bank has no investments, of any kind, with Bank Hapoalim.” Similarly, the Norwegian Finance Ministry recently ordered its sovereign wealth fund to divest from two other Israeli companies–but again, the fund had no investments in those companies.

Such “faux boycotts” are obviously still damaging, because they create the illusion that BDS is gathering steam. Nevertheless, they’re a far cry from real boycotts that do real economic damage.

In short, despite John Kerry’s warnings that if peace talks fail, anti-Israel boycotts will metastasize, BDS remains a fringe movement that can still be thwarted. It will grow to threatening proportions only if Israel and its allies make no effort to challenge it.

One Response to BDS on a Roll? Not So Fast

Subscribe to Evelyn’s Mailing List

Why Israel Needs a Better Political Class

Note: This piece is a response to an essay by Haviv Rettig Gur, which can be found here

Israel’s current political crisis exemplifies the maxim that hard cases make bad law. This case is desperate. Six months after the coronavirus erupted and nine months after the fiscal year began, Israel still lacks both a functioning contact-tracing system and an approved 2020 budget, mainly because Prime Minister Benjamin Netanyahu is more worried about politics than the domestic problems that Israel now confronts. The government’s failure to perform these basic tasks obviously invites the conclusion that civil servants’ far-reaching powers must not only be preserved, but perhaps even increased.

This would be the wrong conclusion. Bureaucrats, especially when they have great power, are vulnerable to the same ills as elected politicians. But unlike politicians, they are completely unaccountable to the public.

That doesn’t mean Haviv Rettig Gur is wrong to deem them indispensable. They provide institutional memory, flesh out elected officials’ policies, and supply information the politicians may not know and options they may not have considered. Yet the current crisis shows in several ways why they neither can nor should substitute for elected politicians.

First, bureaucrats are no less prone to poor judgment than politicians. As evidence, consider Siegal Sadetzki, part of the Netanyahu-led triumvirate that ran Israel’s initial response to the coronavirus. It’s unsurprising that Gur never mentioned Sadetzki even as he lauded the triumvirate’s third member, former Health Ministry Director General Moshe Bar Siman-Tov; she and her fellow Health Ministry staffers are a major reason why Israel still lacks a functional test-and-trace system.

Sadetzki, an epidemiologist, was the ministry’s director of public-health services and the only member of the triumvirate with professional expertise in epidemics (Bar Siman-Tov is an economist). As such, her input was crucial. Yet she adamantly opposed expanding virus testing, even publicly asserting that “Too much testing will increase complacence.” She opposed letting organizations outside the public-health system do lab work for coronavirus tests, even though the system was overwhelmed. She opposed sewage monitoring to track the spread of the virus. And on, and on.

Moreover, even after acknowledging that test-and-trace was necessary, ministry bureaucrats insisted for months that their ministry do the tracing despite its glaringly inadequate manpower. Only in August was the job finally given to the army, which does have the requisite personnel. And the system still isn’t fully operational.

Read more
Archives